These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6271560)

  • 21. Anterograde transport of opioid receptors in rat vagus nerves and dorsal roots of spinal nerves: pharmacology and sensitivity to sodium and guanine nucleotides.
    Zarbin MA; Wamsley JK; Kuhar MJ
    Exp Brain Res; 1990; 81(2):267-78. PubMed ID: 1697808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naltrexone-induced opiate receptor supersensitivity.
    Zukin RS; Sugarman JR; Fitz-Syage ML; Gardner EL; Zukin SR; Gintzler AR
    Brain Res; 1982 Aug; 245(2):285-92. PubMed ID: 6289965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opiate binding sites in bovine adrenal medulla.
    Boublik JH; Clements JA; Herington AC; Funder JW
    J Recept Res; 1983; 3(4):463-79. PubMed ID: 6315932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of 3H-tifluadom binding in guinea-pig brain membranes.
    Burkard WP; Müller PM; Flück N
    J Recept Res; 1984; 4(1-6):165-73. PubMed ID: 6151988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of two different buffers on the high affinity 3H-ethylketocyclazocine and 3H-SKF10047 binding to guinea pig brain membranes.
    Grynne BH; Maurset AR; Holmen AT; Enger M
    Acta Pharmacol Toxicol (Copenh); 1984 Mar; 54(3):195-200. PubMed ID: 6144235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different types of opiate agonists interact distinguishably with mu, delta and kappa opiate binding sites.
    Pfeiffer A; Herz A
    Life Sci; 1982 Sep 20-27; 31(12-13):1355-8. PubMed ID: 6128658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opiate receptor binding profile in the rabbit cerebellum and brain membranes.
    Ho CL; Hammonds RG; Li CH
    Biochem Pharmacol; 1985 Apr; 34(7):925-31. PubMed ID: 2985086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of delta- but not mu-opiate agonist binding by calcium.
    Pfeiffer A; Herz A
    Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):147-53. PubMed ID: 6287305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computer analysis of the effect of beta-endorphin and dynorphin and related compounds on opioid binding to mouse brain membrane.
    Landahl HD; Garzon J; Lee NM
    Comput Biol Med; 1989; 19(3):151-62. PubMed ID: 2566453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photoaffinity labeling of opiate receptors using intrinsically photoactive 3H-opiates.
    Kooper GN; Levinson NR; Copeland CF; Bowen WD
    Mol Pharmacol; 1988 Mar; 33(3):316-26. PubMed ID: 2832721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL; Recht LD; Pasternak GW
    Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High affinity [3H]ethylketazocine binding: evidence for specific kappa receptors.
    Wood PL; Charleson S
    Neuropharmacology; 1982 Mar; 21(3):215-9. PubMed ID: 6122185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Traumatic injury alters opiate receptor binding in rat spinal cord.
    Krumins SA; Faden AI
    Ann Neurol; 1986 May; 19(5):498-501. PubMed ID: 3013077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL; Zarr GD; Brown SR; Cox BM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential postnatal development of mu and delta opiate receptors.
    Wohltmann M; Roth BL; Coscia CJ
    Brain Res; 1982 Apr; 255(4):679-84. PubMed ID: 6280810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of guanyl nucleotides and ions on kappa opioid binding.
    Mack KJ; Lee MF; Weyhenmeyer JA
    Brain Res Bull; 1985 Apr; 14(4):301-6. PubMed ID: 2988712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.